Funding Rounds
CatalYm

CatalYm Series B (2020, $59M)

CatalYm

Innovative immunotherapies developer for cancer patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $59.05M

Raised Date: 2020-01-01

Investors